Fidelity Investments’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-741,276
| Closed | -$4.17M | – | 2777 |
|
2016
Q1 | $4.17M | Sell |
741,276
-418,595
| -36% | -$2.36M | ﹤0.01% | 2209 |
|
2015
Q4 | $20M | Hold |
1,159,871
| – | – | ﹤0.01% | 1696 |
|
2015
Q3 | $24.5M | Hold |
1,159,871
| – | – | ﹤0.01% | 1577 |
|
2015
Q2 | $57.4M | Buy |
1,159,871
+70,450
| +6% | +$3.49M | 0.01% | 1280 |
|
2015
Q1 | $85.3M | Buy |
1,089,421
+28,023
| +3% | +$2.19M | 0.01% | 1095 |
|
2014
Q4 | $64.3M | Buy |
1,061,398
+48,310
| +5% | +$2.93M | 0.01% | 1213 |
|
2014
Q3 | $43.2M | Buy |
1,013,088
+20,930
| +2% | +$892K | 0.01% | 1362 |
|
2014
Q2 | $61.3M | Buy |
992,158
+300,970
| +44% | +$18.6M | 0.01% | 1258 |
|
2014
Q1 | $44.9M | Buy |
691,188
+382,433
| +124% | +$24.9M | 0.01% | 1380 |
|
2013
Q4 | $17.4M | Sell |
308,755
-236,240
| -43% | -$13.3M | ﹤0.01% | 1768 |
|
2013
Q3 | $33.5M | Buy |
544,995
+183,590
| +51% | +$11.3M | 0.01% | 1464 |
|
2013
Q2 | $21.1M | Buy |
+361,405
| New | +$21.1M | ﹤0.01% | 1644 |
|